ArticleJTO clinical and research reports2022

A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC.

Daichi Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.